1. Home
  2. BEAM vs VIAV Comparison

BEAM vs VIAV Comparison

Compare BEAM & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • VIAV
  • Stock Information
  • Founded
  • BEAM 2017
  • VIAV 1923
  • Country
  • BEAM United States
  • VIAV United States
  • Employees
  • BEAM N/A
  • VIAV N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • VIAV Semiconductors
  • Sector
  • BEAM Health Care
  • VIAV Technology
  • Exchange
  • BEAM Nasdaq
  • VIAV Nasdaq
  • Market Cap
  • BEAM 2.3B
  • VIAV 2.2B
  • IPO Year
  • BEAM 2020
  • VIAV 1993
  • Fundamental
  • Price
  • BEAM $22.21
  • VIAV $11.26
  • Analyst Decision
  • BEAM Strong Buy
  • VIAV Buy
  • Analyst Count
  • BEAM 11
  • VIAV 9
  • Target Price
  • BEAM $50.50
  • VIAV $13.19
  • AVG Volume (30 Days)
  • BEAM 2.3M
  • VIAV 2.0M
  • Earning Date
  • BEAM 05-06-2025
  • VIAV 05-01-2025
  • Dividend Yield
  • BEAM N/A
  • VIAV N/A
  • EPS Growth
  • BEAM N/A
  • VIAV N/A
  • EPS
  • BEAM N/A
  • VIAV N/A
  • Revenue
  • BEAM $63,518,000.00
  • VIAV $1,007,000,000.00
  • Revenue This Year
  • BEAM N/A
  • VIAV $10.56
  • Revenue Next Year
  • BEAM $6.32
  • VIAV $7.78
  • P/E Ratio
  • BEAM N/A
  • VIAV N/A
  • Revenue Growth
  • BEAM N/A
  • VIAV N/A
  • 52 Week Low
  • BEAM $20.84
  • VIAV $6.60
  • 52 Week High
  • BEAM $35.25
  • VIAV $12.91
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 38.64
  • VIAV 48.84
  • Support Level
  • BEAM $21.60
  • VIAV $10.63
  • Resistance Level
  • BEAM $24.53
  • VIAV $12.06
  • Average True Range (ATR)
  • BEAM 1.64
  • VIAV 0.29
  • MACD
  • BEAM -0.24
  • VIAV 0.04
  • Stochastic Oscillator
  • BEAM 8.85
  • VIAV 44.44

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: